Larka

Corporate Strategy

Larka assists managers in their decision-making process. We cover issues such as portfolio and business strategy, resource and capital allocation, strategic planning, business development.

 

Corporate Strategy


Our breadth of expertise in pharma & biotech makes us uniquely suited to improve the competitive strategies of your operating units and ensure the value of your company as a whole is more than the sum of its business segments..
 
 

Portfolio And Business Strategy

  • R&D portfolio strategies
  • Generics portfolio strategies
  • Product or business diversification
  • Mix of assets, technologies and processes
  • Value creation at business unit level
  • New business areas growth opportunities
  • M&A and divestment - read more about our M&A solutions ⇀

Resource And Capital Allocation

  • Business units performance analysis
  • Historical data & barriers
  • Capital planning & budgeting process
  • Talent management & reallocation
  • Innovation
  • Risk assessment

Strategic Planning

  • Company environment assessment
  • Organization structure and goals
  • Short term returns Vs. long term strategic objectives
  • Strategy development process
  • Business units interactions and integration
  • Change management

Business Development

  • Sales force assessment
  • Sales & marketing strategy
  • Competition analysis
  • Strategic positioning
  • Geographic expansion
  • Innovation & technology offer
  • Out-licensing, equity participation, asset sales
  • Customised pitch

 

Other Topics

 

Customer Experience

Growth & Value Creation.

API manufacturer is struggling with competitors from emerging countries.

Is This Product The One?

Biotech Co is looking into acquiring a new phase 2 drug candidate.